Life sciences consultancy company Fresci published an analysis titled The Value of Bioclusters During the COVID-19 Pandemic, in which it evaluated 25 biotechnology clusters operating across Europe. Among the bioclusters assessed, only two participants were from the Baltic States, and only one of them was from Lithuania.
iVita’s activities recognized
Health Technology Cluster iVita, developed by the Lithuanian Innovation Centre, attracted international attention and recognition from Fresci, a company specializing in life sciences consulting.
The main goal of the cluster is to create, support, and promote knowledge sharing, innovation, research and experimental development, networking, and cooperation in health technologies and biotechnology, with a focus on the public health sector and its stakeholders.
“The recognition of the iVita cluster in the latest European biocluster report signals that the cluster developed by LIC is visible and that its activities are being noticed internationally. iVita’s inclusion on Fresci’s biocluster map undoubtedly shows that we are developing this cluster in the right direction and must continue pursuing our goals, as consistent work is already bringing greater international attention,” said Gytis Junevičius, Project Manager at the Lithuanian Innovation Centre.
Targeted efforts to become a sustainable, dynamic, and competitive health technology cluster in Europe – one that flexibly interacts with the public health sector and is recognized nationally and internationally – are clearly producing results. The cluster currently has 26 members, and its recognition in Fresci’s analysis shows that its activities are visible internationally.
Additional motivation to keep moving forward
“We are pleased that Lithuania and the iVita cluster were recognized in the latest European biocluster analysis. This clearly shows that we are making the right decisions regarding the cluster’s activities and that our daily work has proven we are a significant player in the European cluster context. Such analyses are valuable not only in terms of knowledge, as they allow us to see, compare, and assess what similar clusters across Europe are doing, but they also provide new motivation to invest even more effort into the cluster’s success,” said Diana Vertelkienė, Head of the iVita cluster.
Fresci’s biocluster analysis assesses key cluster funding sources, essential actors driving cluster activities, services offered by clusters, and other aspects related to cluster operations.
The full Fresci biocluster report is available here: https://lic.lt/wp-content/uploads/2021/10/FRESCI_BIOCLUSTER_INFOG-2021.pdf
